Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for …

KM Chow, WZ So, HJ Lee, A Lee, DWT Yap… - European Urology, 2023 - Elsevier
Context Whether prostate-specific membrane antigen positron emission tomography (PSMA-
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …

Using PSMA imaging for prognostication in localized and advanced prostate cancer

MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, hel** to …

Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter …

TA Hope, M Eiber, WR Armstrong, R Juarez… - JAMA …, 2021 - jamanetwork.com
Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …

[HTML][HTML] Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very …

DS Surasi, M Eiber, T Maurer, MA Preston, BT Helfand… - European urology, 2023 - Elsevier
Abstract Background Radiohybrid (rh) 18 F-rhPSMA-7.3 is a novel high-affinity prostate-
specific membrane antigen (PSMA)-targeting radiopharmaceutical for prostate cancer (PCa) …

Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly …

A Stabile, A Pellegrino, E Mazzone… - European Urology …, 2022 - Elsevier
Context The role of positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …

Incorporating prostate-specific membrane antigen positron emission tomography in management decisions for men with newly diagnosed or biochemically recurrent …

L Bukavina, AN Luckenbaugh, MS Hofman, T Hope… - European Urology, 2023 - Elsevier
Context Prostate-specific membrane antigen (PSMA) is a promising molecular target for
prostate cancer (PCa) that has allowed the development of a novel diagnostic approach to …

[HTML][HTML] Targeting PSMA revolutionizes the role of nuclear medicine in diagnosis and treatment of prostate cancer

WI Luining, MCF Cysouw, D Meijer, NH Hendrikse… - Cancers, 2022 - mdpi.com
Simple Summary Imaging plays a crucial role in the accurate staging of prostate cancer.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells, and …

68Ga-NC-BCH whole-body PET imaging rapidly targets claudin18. 2 in lesions in gastrointestinal cancer patients

C Qi, R Guo, Y Chen, C Li, C Liu… - Journal of Nuclear …, 2024 - jnm.snmjournals.org
68Ga-labeled nanobody (68Ga-NC-BCH) is a single-domain antibody–based PET imaging
agent. We conducted a first-in-humans study of 68Ga-NC-BCH for PET to determine its in …

The impact of positron emission tomography imaging and tumor molecular profiling on risk stratification, treatment choice, and oncological outcomes of patients with …

A Sood, AU Kishan, CP Evans, FY Feng… - European Urology …, 2024 - Elsevier
Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

S Malaspina, M Anttinen, P Taimen, I Jambor… - European Journal of …, 2021 - Springer
Purpose To prospectively compare 18 F-prostate-specific membrane antigen (PSMA)-1007
positron emission tomography (PET)/CT, whole-body magnetic resonance imaging (WBMRI) …